Integration of multiple acquisitions may strain margins
Management plans to slow acquisitions for 2-3 quarters to integrate, but cost synergies may take longer, pressuring margins.
medium · management_commentaryEntero Healthcare Solutions Ltd — Q3 FY26
Entero Healthcare delivered a strong Q3 FY26 with revenue of ₹1,771 crore (+26% YoY) and EBITDA of ₹68 crore (+36% YoY), driven by organic growth of 17.1% and contributions from...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Rising other expenses due to medtech demand generation
Medtech acquisitions bring higher gross margins but also higher employee and marketing costs, which could limit net margin expansion.
medium · analyst_questionCompetition from PharmEasy resuming acquisitions
Analyst raised concern that PharmEasy's recovery could increase competition for acquisition targets, though management downplayed the risk.
low · analyst_questionCarry-forward tax losses may be exhausted by next year
Effective tax rate of 13-18% is low due to carry-forward losses; once exhausted, tax rate could normalize to 25%, impacting PAT.
medium · analyst_question